News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 12, 2016, 17:00 ET Valeant Pharmaceuticals Receives Notice Of Default From Bondholders Due To Delayed 10-K Filing

Notice Does Not Accelerate Any of the Company's Indebtedness Company Has Until June 11, 2016 to Cure Default By Filing 10-K Company is on...


Apr 07, 2016, 07:30 ET Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment

Intends to File 10-K on or before April 29, 2016, as Previously Disclosed  Valeant Pharmaceuticals International, Inc. (NYSE: VRX and...


Apr 05, 2016, 08:48 ET Valeant Ad Hoc Committee Announces Completion Of Its Review Of Philidor And Related Accounting Matters

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the ad hoc committee of the board of directors (the "Ad...


Apr 04, 2016, 07:00 ET Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR

-Agency requests standard three-month extension to review additional solicited information- -New PDUFA date set for July 19, 2016- Valeant...


Mar 21, 2016, 08:58 ET Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update

Initiates Search for New CEO; J. Michael Pearson to Remain as CEO Until Successor is Named William A. Ackman Joins Board of Directors; Katharine...


Mar 15, 2016, 10:21 ET Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information

Company Provides New 2016 Guidance  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") today announced...


Mar 09, 2016, 17:30 ET Valeant And R&O Pharmacy End Litigation

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and R&O Pharmacy, LLC (R&O) today announced that they have jointly...


Mar 09, 2016, 08:00 ET Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Dr. Fred Eshelman, Mr. Stephen Fraidin and Mr. Thomas W....


Mar 07, 2016, 08:00 ET Valeant Pharmaceuticals To Hold Conference Call On March 15, 2016

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on...


Mar 03, 2016, 08:00 ET Valeant Pharmaceuticals Comments On Management Change

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today issued the following comments in response to inquiries from investors...


Mar 02, 2016, 19:01 ET Valeant Pharmaceuticals Announces Management Change

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today confirmed that Deb Jorn has resigned as Executive Vice President,...


Feb 28, 2016, 19:27 ET Valeant Pharmaceuticals Announces Management And Business Update

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that J. Michael Pearson returns as Valeant's chief...


Feb 22, 2016, 22:09 ET Valeant Ad Hoc Committee has Made Substantial Progress in Its Review of Philidor and Related Accounting Matters

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that based on the work...


Jan 25, 2016, 08:00 ET Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has...


Jan 25, 2016, 07:00 ET Valeant Provides Update On J. Michael Pearson

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today released a memo sent to Valeant employees from J. Michael Pearson,...


Jan 06, 2016, 08:27 ET Valeant Names Howard B. Schiller Interim CEO

Robert Ingram, Lead Independent Director, to Serve as Interim Chairman J. Michael Pearson to Remain on Medical Leave of Absence...


Jan 04, 2016, 17:00 ET Valeant Pharmaceuticals To Present At The 34th Annual J.P. Morgan Healthcare Conference

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that members of its senior management team will present at the...


Dec 28, 2015, 08:00 ET Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence

Interim Office of the CEO and Committee of the Board of Directors Formed Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX)...


Dec 28, 2015, 08:00 ET Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence

Interim Office of the CEO and Committee of the Board of Directors Formed Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX)...


Dec 18, 2015, 17:56 ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Valeant Pharmaceuticals International, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 21, 2015 - VRX

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities...